JP2009542205A5 - - Google Patents

Download PDF

Info

Publication number
JP2009542205A5
JP2009542205A5 JP2009518026A JP2009518026A JP2009542205A5 JP 2009542205 A5 JP2009542205 A5 JP 2009542205A5 JP 2009518026 A JP2009518026 A JP 2009518026A JP 2009518026 A JP2009518026 A JP 2009518026A JP 2009542205 A5 JP2009542205 A5 JP 2009542205A5
Authority
JP
Japan
Prior art keywords
epa
culture
microorganism
composition
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009518026A
Other languages
English (en)
Japanese (ja)
Other versions
JP5658876B2 (ja
JP2009542205A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/NZ2007/000172 external-priority patent/WO2008004900A1/en
Publication of JP2009542205A publication Critical patent/JP2009542205A/ja
Publication of JP2009542205A5 publication Critical patent/JP2009542205A5/ja
Application granted granted Critical
Publication of JP5658876B2 publication Critical patent/JP5658876B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009518026A 2006-07-05 2007-07-05 大規模従属栄養培養領域にて産生される超高純度ｅｐａと極性脂質 Expired - Fee Related JP5658876B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ54833906 2006-07-05
NZ548339 2006-07-05
PCT/NZ2007/000172 WO2008004900A1 (en) 2006-07-05 2007-07-05 Production of ultrapure epa and polar lipids from largely heterotrophic culture

Publications (3)

Publication Number Publication Date
JP2009542205A JP2009542205A (ja) 2009-12-03
JP2009542205A5 true JP2009542205A5 (https=) 2013-09-12
JP5658876B2 JP5658876B2 (ja) 2015-01-28

Family

ID=38894787

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009518026A Expired - Fee Related JP5658876B2 (ja) 2006-07-05 2007-07-05 大規模従属栄養培養領域にて産生される超高純度ｅｐａと極性脂質

Country Status (8)

Country Link
US (3) US8877465B2 (https=)
EP (1) EP2044208A4 (https=)
JP (1) JP5658876B2 (https=)
AU (1) AU2007270135B9 (https=)
CA (1) CA2656311C (https=)
NO (1) NO20090531L (https=)
NZ (1) NZ573719A (https=)
WO (1) WO2008004900A1 (https=)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2336307C2 (ru) 2000-01-19 2008-10-20 Мартек Биосайнсис Корпорейшн Способ получения липидов (варианты) и липиды, полученные этим способом
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
WO2010028067A1 (en) 2008-09-02 2010-03-11 Amarin Corporation Plc Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same
KR101383006B1 (ko) 2009-02-10 2014-04-08 아마린 파마, 인크. 고중성지방혈증 치료 방법
PT3278665T (pt) 2009-04-29 2020-11-19 Amarin Pharmaceuticals Ie Ltd Composição farmacêutica estável e métodos de utilização das mesmas
SG175390A1 (en) 2009-04-29 2011-12-29 Amarin Corp Plc Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
CN106074486A (zh) 2009-06-15 2016-11-09 阿马里纳药物爱尔兰有限公司 在相伴他汀类疗法的对象中降低甘油三酯、没有增加ldl‑c水平的组合物和方法
US8637298B2 (en) 2009-06-16 2014-01-28 E I Du Pont De Nemours And Company Optimized strains of yarrowia lipolytica for high eicosapentaenoic acid production
CN101613724B (zh) * 2009-07-28 2011-04-06 嘉吉烯王生物工程(湖北)有限公司 重复利用高山被孢霉菌粕制备花生四烯酸的方法
BR112012005844B1 (pt) * 2009-09-18 2019-11-26 Phycoil Biotechnology International, Inc. Método para cultivar microalgas capazes de crescimento heterotrófico, método para fabricar um material, e sistema de biorreator
US20110071176A1 (en) 2009-09-23 2011-03-24 Amarin Pharma, Inc. Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
PE20130491A1 (es) * 2009-12-30 2013-05-02 Basf Pharma Callanish Ltd Proceso simulado de separacion cromatografica de lecho movil para la purificacion de acidos grasos poliinsaturados
AU2013204090B2 (en) * 2009-12-30 2015-01-29 Basf Pharma (Callanish) Limited Simulated moving bed chromatographic separation process
WO2011090493A1 (en) 2010-01-19 2011-07-28 Martek Biosciences Corporation Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
RU2606853C2 (ru) * 2010-03-04 2017-01-10 Амарин Фармасьютикалз Айрлэнд Лимитед (Апил) Композиции и способы лечения и/или предотвращения сердечно-сосудистого заболевания
CN103124791B (zh) 2010-06-01 2016-08-24 帝斯曼知识产权资产管理有限公司 从细胞中提取脂质以及由此获得的产品
US8769868B2 (en) 2010-06-09 2014-07-08 Photonz Corporation Limited Compositions comprising eicosapentaenoic acid suitable for high purification
FR2964667B1 (fr) * 2010-09-15 2014-08-22 Fermentalg Procede de culture d'algues unicellulaires mixotrophes en presence d'un apport lumineux discontinu sous forme de flashs
WO2012047120A1 (en) * 2010-10-06 2012-04-12 Photonz Corporation Limited Heterotrophic microbial production of xanthophyll pigments
US10479969B2 (en) 2010-10-11 2019-11-19 Phycoil Biotechnology International. Inc. Utilization of wastewater for microalgal cultivation
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
NZ778131A (en) 2010-11-29 2023-03-31 Amarin Pharmaceuticals Ie Ltd Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
WO2012103685A1 (en) * 2011-02-01 2012-08-09 Nippon Suisan Kaisha, Ltd. Sexual function improving agent
CN103327982A (zh) * 2011-02-01 2013-09-25 日本水产株式会社 性功能改善剂
CN103354839A (zh) * 2011-02-11 2013-10-16 纳幕尔杜邦公司 二十碳五烯酸浓缩物
GB201111601D0 (en) 2011-07-06 2011-08-24 Equateq Ltd New process
GB201111595D0 (en) 2011-07-06 2011-08-24 Equateq Ltd Improved process
GB201111594D0 (en) 2011-07-06 2011-08-24 Equateq Ltd New improved process
GB201111591D0 (en) 2011-07-06 2011-08-24 Equateq Ltd Further new process
GB201111589D0 (en) 2011-07-06 2011-08-24 Equateq Ltd New modified process
HK1198515A1 (en) * 2011-07-21 2015-05-15 Dsm Ip Assets B.V. Fatty acid compositions
EP2775837A4 (en) 2011-11-07 2015-10-28 Amarin Pharmaceuticals Ie Ltd METHODS OF TREATING HYPERTRIGLYCERIDEMIA
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
ES2891473T3 (es) 2012-01-06 2022-01-28 Amarin Pharmaceuticals Ie Ltd Composiciones y métodos para reducir los niveles de alta sensibilidad (hs-CRP) en un sujeto
FR2988098A1 (fr) * 2012-03-16 2013-09-20 Fermentalg Production d'acide docosahexaenoique en mode mixotrophe par nitzschia
JPWO2013168310A1 (ja) 2012-05-10 2015-12-24 国立大学法人京都大学 オキソ脂肪酸及び希少脂肪酸の製造法
EP2861227A4 (en) 2012-06-17 2016-01-27 Matinas Biopharma Inc OMEGA-3 PENTAIC ACID COMPOSITIONS AND METHODS OF USE
EP4338805B1 (en) 2012-06-29 2025-06-04 Amarin Pharmaceuticals Ireland Limited Eicosapentaenoic acid ethyl ester for use in reducing the risk of non-fatal myocardial infarction in a subject on statin therapy
WO2014074552A2 (en) 2012-11-06 2014-05-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
WO2014074770A2 (en) 2012-11-09 2014-05-15 Heliae Development, Llc Balanced mixotrophy methods
WO2014074772A1 (en) 2012-11-09 2014-05-15 Heliae Development, Llc Mixotrophic, phototrophic, and heterotrophic combination methods and systems
CA2894183A1 (en) * 2012-12-06 2014-06-12 Matinas Biopharma, Inc. Omega-3 pentaenoic acid compositions and methods of use
US9629820B2 (en) 2012-12-24 2017-04-25 Qualitas Health, Ltd. Eicosapentaenoic acid (EPA) formulations
MX372724B (es) * 2012-12-24 2020-06-19 Qualitas Health Inc Formulaciones de acido eicosapentaenoico (epa).
US10123986B2 (en) 2012-12-24 2018-11-13 Qualitas Health, Ltd. Eicosapentaenoic acid (EPA) formulations
US9814733B2 (en) 2012-12-31 2017-11-14 A,arin Pharmaceuticals Ireland Limited Compositions comprising EPA and obeticholic acid and methods of use thereof
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
GB201300354D0 (en) * 2013-01-09 2013-02-20 Basf Pharma Callanish Ltd Multi-step separation process
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US9662307B2 (en) 2013-02-19 2017-05-30 The Regents Of The University Of Colorado Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
US9283201B2 (en) 2013-03-14 2016-03-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for treating or preventing obesity in a subject in need thereof
US20140288014A1 (en) * 2013-03-15 2014-09-25 Aurora Algae, Inc. Compositions of crude algal oil
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US20140275613A1 (en) * 2013-03-15 2014-09-18 Aurora Algae, Inc. Conversion of free fatty acids to ethyl esters
US8802880B1 (en) 2013-05-07 2014-08-12 Group Novasep Chromatographic process for the production of highly purified polyunsaturated fatty acids
US9428711B2 (en) 2013-05-07 2016-08-30 Groupe Novasep Chromatographic process for the production of highly purified polyunsaturated fatty acids
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
ES2825062T3 (es) 2013-08-01 2021-05-14 Fermentalg Métodos para la producción de biomasa de diatomeas
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
NL2011472C2 (en) 2013-09-19 2015-03-23 Univ Delft Tech Storage compound production by phototrophic diatoms.
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
EP2883860B1 (fr) 2013-12-11 2016-08-24 Novasep Process Procédé chromatographique de production d'acides gras polyinsaturés
AU2014369042B2 (en) 2013-12-20 2020-04-30 Dsm Ip Assets B.V. Processes for obtaining microbial oil from microbial cells
SG11201605043TA (en) 2013-12-20 2016-07-28 Dsm Ip Assets Bv Processes for obtaining microbial oil from microbial cells
PL3082793T3 (pl) 2013-12-20 2020-10-05 Dsm Ip Assets B.V. Sposoby otrzymywania oleju drobnoustrojowego z komórek drobnoustrojowych
NZ721409A (en) 2013-12-20 2022-10-28 Dsm Ip Assets Bv Processes for obtaining microbial oil from microbial cells
WO2015095693A2 (en) 2013-12-20 2015-06-25 Dsm Ip Assets B.V. Processes for obtaining microbial oil from microbial cells
JP6303017B2 (ja) 2014-01-07 2018-03-28 ノヴァセプ プロセスＮｏｖａｓｅｐ Ｐｒｏｃｅｓｓ 芳香族アミノ酸を精製する方法
JP2015146788A (ja) * 2014-02-07 2015-08-20 三菱マテリアル株式会社 藻類培養方法及び藻類培養装置
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
WO2015195662A1 (en) 2014-06-16 2015-12-23 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
PL3469085T3 (pl) * 2016-06-08 2021-12-27 Swedish Algae Factory Ab Skorupki uzyskane z bentosowych okrzemek pierzastych zebranych w przemysłowym procesu tworzeniu biofilmu
CN105912054B (zh) * 2016-06-24 2018-11-20 国网山东省电力公司聊城供电公司 一种油色谱在线装置柜的温控系统及其工作方法与应用
WO2018213663A1 (en) 2017-05-19 2018-11-22 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
CN107099379A (zh) * 2017-06-09 2017-08-29 云南中烟工业有限责任公司 一种用于电子烟的津巴布韦烟草净油
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
FR3085962B1 (fr) 2018-09-14 2021-06-18 Fermentalg Procede d'extracton d'une huile riche en pufa
KR20210110890A (ko) 2018-09-24 2021-09-09 애머린 파마슈티칼스 아일랜드 리미티드 대상체에서 심혈관 사건의 위험도를 감소시키는 방법
JP7395144B2 (ja) * 2019-04-05 2023-12-11 三菱重工機械システム株式会社 微細藻培養方法および微細藻培養装置
US12427134B2 (en) 2019-11-12 2025-09-30 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of cardiovascular events in a subject with atrial fibrillation and/or atrial flutter
WO2021211990A1 (en) * 2020-04-17 2021-10-21 Wake Forest University Lipid compositions and methods of preparation thereof
GB202016236D0 (en) * 2020-10-13 2020-11-25 Givaudan Sa Composition
AU2022263358A1 (en) 2021-04-21 2023-11-30 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of heart failure

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1969433U (de) * 1967-04-14 1967-09-28 Bernhard Dipl Ing Winkler Beschilderungselement.
JPS5946225A (ja) * 1982-09-09 1984-03-15 Kogyo Kaihatsu Kenkyusho 抗動脈硬化剤の製造方法
JPS6163624A (ja) * 1984-09-05 1986-04-01 Nisshin Oil Mills Ltd:The エイコサペンタエン酸含量の高い糖脂質の製造法
JPH0297373A (ja) * 1988-09-30 1990-04-09 Koujiyouen:Kk ビールの製造方法
JPH0297393A (ja) 1988-10-03 1990-04-09 Sagami Chem Res Center エイコサペンタエン酸を含むリン脂質組成物の海洋微生物による製造法
JPH02145191A (ja) * 1988-11-29 1990-06-04 Tosoh Corp 海洋性微生物からの高度不飽和脂肪酸の分離方法
US5244921A (en) * 1990-03-21 1993-09-14 Martek Corporation Eicosapentaenoic acids and methods for their production
AU6821294A (en) * 1993-04-30 1994-11-21 Rodner R. Winget Anti-inflammatory compositions containing eicosapentaenoic acid bearing monogalactosyldiacylglycerol and methods relating thereto
GB9404483D0 (en) 1994-03-08 1994-04-20 Norsk Hydro As Refining marine oil compositions
DE19629433A1 (de) 1996-07-22 1998-01-29 Hoechst Ag Omega-3-fettsäurenenthaltende Zubereitung aus Mikroorganismen als Prophylaktikum bzw. Therapeutikum gegen parasitäre Erkrankungen beim Tier
JP3836231B2 (ja) * 1997-10-17 2006-10-25 日本化学飼料株式会社 ホタテガイ中腸腺から得られる高度不飽和脂肪酸含有油及びその製造方法
AU2004235641B2 (en) * 1999-01-27 2006-09-14 Amarin Neuroscience Limited Highly purified ethyl EPA and other EPA derivatives for psychiatric and neurological disorders
CA2273570A1 (en) * 1999-05-31 2000-11-30 Jfs Envirohealth Ltd. Concentration and purification of polyunsaturated fatty acid esters by distillation-enzymatic transesterification coupling
JP4170542B2 (ja) * 1999-11-18 2008-10-22 日油株式会社 高度不飽和脂肪酸誘導体の製造方法及び高純度エイコサペンタエン酸誘導体
RU2336307C2 (ru) * 2000-01-19 2008-10-20 Мартек Биосайнсис Корпорейшн Способ получения липидов (варианты) и липиды, полученные этим способом
AU2002309856B2 (en) * 2001-05-14 2008-10-23 Dsm Ip Assets B.V. Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms
AU2003272095B2 (en) * 2002-10-11 2010-04-08 Nippon Suisan Kaisha, Ltd. Process for producing microbial fat or oil having lowered unsaponifiable matter content and said fat or oil
GB0301701D0 (en) 2003-01-24 2003-02-26 Ensay Ltd Psoriasis and Eicosapentaenoic acid
US8557551B2 (en) * 2004-09-10 2013-10-15 Dsm Ip Assets B.V. Compositions and methods for making and modifying oils
US20100021555A1 (en) * 2004-10-15 2010-01-28 Karl Geiringer Compositions containing high omega-3 and low saturated fatty acid levels
US20070225370A1 (en) * 2006-03-21 2007-09-27 Joar Opheim Nutritional Compositions and Methods

Similar Documents

Publication Publication Date Title
JP2009542205A5 (https=)
CN104394702B (zh) 用于不断富集由微藻产生的、具有dha乙酯的一种油的方法
US9045784B2 (en) Method for production of euglena containing wax ester at high content, and method for production of wax ester
JP2009149910A5 (https=)
ES2421355T3 (es) Procedimiento para la producción de bioproductos
CN105331572B (zh) 一种发酵高产dha的方法
CN107460216A (zh) 一种利用烟气生产微藻油脂的方法
CN103189520B (zh) 利用生物物质的2-吡咯烷酮的制备方法
JP2018537105A (ja) 高度不飽和脂肪酸、特にオメガ３クラス脂肪酸に富む脂質を含有する原生生物を増殖する方法、及び増殖した原生生物又はその脂質を生産するためのその実施
CN104480152B (zh) 一种提高裂殖壶菌油脂中二十二碳六烯酸含量的方法
CN100503811C (zh) 裂殖壶菌(Schizochytrium)WZU4771及其在制备DHA粉末和油脂中的应用
Gastelum-Franco et al. Preliminary evaluation of the green microalga Dunaliella salina as a potential feedstock for biodiesel: effect of molasses on growth and lipid profile
AU2012284645A1 (en) Method for obtaining an open phototrophic culture with improved storage compound production capacity
CN105713934A (zh) 一种生产微藻油脂的方法
CN101717818B (zh) 一种筛选产多不饱和脂肪酸微生物的方法
CN104894176B (zh) 一种调控裂殖壶菌油脂中dpa/dha比例的调控因子及其调控方法
US20110089370A1 (en) Lipophilic Preparations
CN107460217A (zh) 一种混合培养制备微藻油脂的方法
JP2015505331A (ja) 煙草植物からのバイオ燃料の生産
CN100552029C (zh) 毕赤酵母ω3-脂肪酸脱氢酶启动子序列及其应用
KR101625074B1 (ko) 산화 스트레스를 이용하여 지질함량을 증가시킨 미세조류 및 그의 제조방법
KR20110122426A (ko) Ｔｈｒａｕｓｔｏｃｈｔｒｉｄ계 미세조류의 배양방법
Boopathy et al. Mass cultivation of new algae Tetraselmis straiata BBRR1 under open raceway ponds for biodiesel and biocrude production
KR20260042216A (ko) 높은 epa 함량을 갖는 미생물 오일 및 이의 제조 방법
CN104046568A (zh) 一种富含dha破囊壶菌的培养液及培养方法